Accelerated drug approvals present a mounting challenge to oncologists and raises concerns about cost effectiveness for health system finance leaders
In the past year, Americans have witnessed two extremes of the FDA’s accelerated approval process, exposing both profound strengths and worrisome weaknesses. Finance leaders should keep informed about new drug treatment options, their associated costs and efficacy and whether lower-cost alternatives that have the same efficacy are available so they can engage in meaningful conversations with clinicians about which options truly promote cost effectiveness of health.
How to create an employer-friendly healthcare center of excellence
Increasing health expenditures and the pressures of the recent pandemic have contributed to the development of a new type of center of excellence (COE), called the future-state COE, which is designed to better address the needs of large employers. This COE model incorporates value-based contracting and a strong incentive design into a service-line strategy to create employee health programs that benefit employers, patients and providers alike.
Relief meets reality: The pandemic is not over yet
HFMA President and CEO Joe Fifer reflects on another challenging year for healthcare.
Jill Geisler: 9 ways difficult conversations go south and how to keep that from happening
Avoiding difficult conversations can lead to unhealthy organizations. Jill Geisler talks about common ways conversations can derail and how leaders can get them back on track.
6 things leaders can do to foster civility in the workplace
Times are turbulent, and people often feel empowered to express their opinions, even in negative ways. Jill Geisler shares things leaders can do to promote civility in the workplace and keep teams working well together.
Social isolation affects many populations during the holidays
Many experience higher rates of loneliness and social isolation during the holiday season. Those working in healthcare are in a unique position to identify those at risk and promote health equity.
Eric Jordahl: Hospitals and health systems face risk as the Federal Reserve pursues normalization
Labor market concerns and growing inflationary pressures pose challenges that the Federal Reserve must address as the economy recovers from the COVID-19 pandemic.
Gail Wilensky: Physician payment and SDoH challenges loom large on nation’s path to value
Two primary obstacles stand in the way of the nation's ability to achieve cost-effective health and healthcare delivery: the slow transition to value-based payment by physicians and the need to address social determinants of health.
Martin Bluth: Blood donation — Why it should be on healthcare finance leaders’ radar
Blood donations should be a top-of-mind concern for hospital and health system finance leaders given that a steady supply of blood donations is among the most critical lifesaving needs for their organizations.
Relief meets reality: The healthcare workforce is still reeling from COVID-19’s impact
HFMA President and CEO Joe Fifer reflects on another challenging year for healthcare.